ALMS Stock: Alumis Inc. Common Stock Stock Price, Analysis & Insights
Get live alms stock price $11.12, comprehensive Alumis Inc. Common Stock stock analysis, charts, news, and expert forecast. Real-time alms stock data and investment insights.
Loading chart...
Company Overview
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis, systemic lupus erythematosus, and non-infectious uveitis; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. The company was incorporated in 2021 and is headquartered in South San Francisco, California.
Company Information
- CEO
- Martin Babler
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 168
Contact Information
- Website
- https://www.alumis.com
- Address
- 280 East Grand Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Listed on major US exchange (NASDAQ) providing liquidity and transparency
✓ Lower volatility stock (Beta: -1.86) may provide portfolio stability
Business Model & Strategy
Alumis Inc. Common Stock operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Martin Babler, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Alumis Inc. Common Stock competes in the Biotechnology within the broader Healthcare. With 1.2 billion in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ, Alumis Inc. Common Stock provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Alumis Inc. Common Stock should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Alumis Inc. Common Stock shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Alumis Inc. Common Stock
- ⚠Investors should consider how Alumis Inc. Common Stock fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.16B
P/E Ratio
-5.17
Beta
-1.86
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 1.16B market capitalization
- Trading Volume: 4.35M shares traded today
- Price Range: 52-week range of $2.76 - $11.30
- Exchange: Listed on NASDAQ
Financial Metrics
Market Analysis for Alumis Inc. Common Stock
Alumis Inc. Common Stock (ALMS) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 1.16B, the company represents a significant player in its market. The stock is currently trading at $11.12 with a positivedaily change of 33.98%.
The company's 168 employee base and presence on the NASDAQexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -5.17, beta of -1.86, and 52-week price range from $2.76 to $11.30when evaluating investment opportunities.
Why Invest in Alumis Inc. Common Stock?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ)
- • Experienced leadership under Martin Babler
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.